The sexually dimorphic role of adipose and adipocyte estrogen receptors in modulating adipose tissue expansion, inflammation, and fibrosis

Molecular Metabolism

Volumn 2, Issue 3, 2013, Pages 227-242

  Davis, Kathryn E ^a   D Neinast, Michael ^a   Sun, Kai ^a   M Skiles, William ^a   D Bills, Jessica ^a   A Zehr, Jordan ^a   Zeve, Daniel ^b   D Hahner, Lisa ^a   W Cox, Derek ^a   M Gent, Lana ^a   Xu, Yong ^c   V Wang, Zhao ^a   A Khan, Sohaib ^d   Clegg, Deborah J ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Estrogen receptor alpha (ER ); Fibrosis; Inflammation; White adipose tissue (WAT)

Indexed keywords

ADIPONECTIN; COLLAGEN TYPE 6; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; PROTEIN LYSINE 6 OXIDASE; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BODY COMPOSITION; CELL DIFFERENTIATION; CELL INFILTRATION; CELL SPECIFICITY; CONTROLLED STUDY; DOWN REGULATION; FEMALE; FIBROSIS; GLUCOSE HOMEOSTASIS; IMMUNOREACTIVITY; MACROPHAGE; MALE; MORPHOLOGY; MOUSE; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; SEX DIFFERENCE; SIGNAL TRANSDUCTION; SOFT TISSUE INFLAMMATION; TISSUE EXPANSION; TISSUE SPECIFICITY; UPREGULATION;

MUS;

EID: 84883240503     PISSN: 22128778     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molmet.2013.05.006     Document Type: Article

References (42)

1. Despres J.P. Abdominal obesity as important component of insulin-resistance syndrome. Nutrition 1993, 9(5):452-459.
2. Kannel W.B., et al. Regional obesity and risk of cardiovascular disease; the Framingham Study. Journal of Clinical Epidemiology 1991, 44(2):183-190.
3. Lee C.G., et al. Adipokines, inflammation, and visceral adiposity across the menopausal transition: a prospective study. Journal of Clinical Endocrinology and Metabolism 2009, 94(4):1104-1110.
4. Dua A., et al. Leptin: a significant indicator of total body fat but not of visceral fat and insulin insensitivity in African-American women. Diabetes 1996, 45(11):1635-1637.
5. Kotani K., et al. Sexual dimorphism of age-related changes in whole-body fat distribution in the obese. International Journal of Obesity and Related Metabolic Disorders 1994, 18(4). 207-2.
6. Legato M.J. Gender-specific aspects of obesity. International Journal of Fertility and Women's Medicine 1997, 42(3):184-197.
7. Legato M.J. Gender-specific physiology: how real is it? How important is it?. International Journal of Fertility and Women's Medicine 1997, 42(1):19-29.
8. Havel P.J., et al. Gender differences in plasma leptin concentrations. Nature Medicine 1996, 2(9):949-950.
9. Payette C., et al. Sex differences in postprandial plasma tumor necrosis factor-alpha, interleukin-6, and C-reactive protein concentrations. Metabolism 2009, 58(11):1593-1601.
10. Grove K.L., et al. A microarray analysis of sexual dimorphism of adipose tissues in high-fat-diet-induced obese mice. International Journal of Obesity (London) 2010, 34(6):989-1000.
11. Macotela Y., et al. Sex and depot differences in adipocyte insulin sensitivity and glucose metabolism. Diabetes 2009, 58(4):803-812.
12. Schneider G., et al. Increased estrogen production in obese men. Journal of Clinical Endocrinology and Metabolism 1979, 48(4):633-638.
13. Tchernof A., et al. Relation of steroid hormones to glucose tolerance and plasma insulin levels in men. Importance of visceral adipose tissue. Diabetes Care 1995, 18(3):292-299.
14. Gambacciani M., et al. Body weight, body fat distribution, and hormonal replacement therapy in early postmenopausal women. Journal of Clinical Endocrinology and Metabolism 1997, 82(2):414-417.
15. Haarbo J., Hansen B.F., Christiansen C. Hormone replacement therapy prevents coronary artery disease in ovariectomized cholesterol-fed rabbits. Acta Pathologica, Microbiologica et Immunologica Scandinavica 1991, 99(8):721-727.
16. Haarbo J., et al. Postmenopausal hormone replacement therapy prevents central distribution of body fat after menopause. Metabolism 1991, 40(12):1323-1326.
17. D'Eon T.M., et al. Estrogen regulation of adiposity and fuel partitioning. Evidence of genomic and non-genomic regulation of lipogenic and oxidative pathways. Journal of Biological Chemistry 2005, 280(43):35983-35991.
18. Matelski H., et al. Randomized trial of estrogen vs. tamoxifen therapy for advanced breast cancer. American Journal of Clinical Oncology 1985, 8(2):128-133.
19. Clegg D.J., et al. Gonadal hormones determine sensitivity to central leptin and insulin. Diabetes 2006, 55(4):978-987.
20. Crandall D.L., et al. Identification of estrogen receptor beta RNA in human breast and abdominal subcutaneous adipose tissue. Biochemical and Biophysical Research Communications 1998, 248(3):523-526.
21. Kuiper G.G., et al. Cloning of a novel receptor expressed in rat prostate and ovary. Proceedings of the National Academy of Sciences of the United States of America 1996, 93(12):5925-5930.
22. Ribas V., et al. Impaired oxidative metabolism and inflammation are associated with insulin resistance in ERalpha-deficient mice. American Journal of Physiology-Endocrinology and Metabolism 2010, 298(2):E304-E319.
23. Rogers N.H., et al. Reduced energy expenditure and increased inflammation are early events in the development of ovariectomy-induced obesity. Endocrinology 2009, 150(5):2161-2168.
24. Mizutani T., et al. Identification of estrogen receptor in human adipose tissue and adipocytes. Journal of Clinical Endocrinology and Metabolism 1994, 78(4):950-954.
25. Pedersen S.B., et al. Identification of steroid receptors in human adipose tissue. European Journal of Clinical Investigation 1996, 26(12):1051-1056.
26. Bronnegard M., et al. Lack of evidence for estrogen and progesterone receptors in human adipose tissue. Journal of Steroid Biochemistry and Molecular Biology 1994, 51(5-6):275-281.
27. Rebuffe-Scrive M., et al. Steroid hormone receptors in human adipose tissues. Journal of Clinical Endocrinology and Metabolism 1990, 71(5):1215-1219.
28. Okura T., et al. Association of polymorphisms in the estrogen receptor alpha gene with body fat distribution. International Journal of Obesity and Related Metabolic Disorders 2003, 27(9):1020-1027.
29. Heine P.A., et al. Increased adipose tissue in male and female estrogen receptor-alpha knockout mice. Proceedings of the National Academy of Sciences of the United States of America 2000, 97(23):12729-12734.
30. Cooke P.S., et al. The role of estrogen and estrogen receptor-alpha in male adipose tissue. Molecular and Cellular Endocrinology 2001, 178(1-2):147-154.
31. Feng Y., et al. Estrogen receptor-alpha expression in the mammary epithelium is required for ductal and alveolar morphogenesis in mice. Proceedings of the National Academy of Sciences of the United States of America 2007, 104(37):14718-14723.
32. Wang Y., et al. GSK-3beta mediates in the progesterone inhibition of estrogen induced cyclin D2 nuclear localization and cell proliferation in cyclin D1-/- mouse uterine epithelium. FEBS Letters 2007, 581(16):3069-3075.
33. Wang Z.V., et al. Identification and characterization of a promoter cassette conferring adipocyte-specific gene expression. Endocrinology 2010, 151(6):2933-2939.
34. Tang W., et al. White fat progenitor cells reside in the adipose vasculature. Science 2008, 322(5901):583-586.
35. Karas R.H., et al. Effects of estrogen on the vascular injury response in estrogen receptor alpha, beta (double) knockout mice. Circulation Research 2001, 89(6):534-539.
36. Strissel K.J., et al. Adipocyte death, adipose tissue remodeling, and obesity complications. Diabetes 2007, 56(12):2910-2918.
37. Stubbins R.E., et al. Estrogen modulates abdominal adiposity and protects female mice from obesity and impaired glucose tolerance. European Journal of Nutrition 2012, 51(7):861-870.
38. Ribas V., et al. Myeloid-specific estrogen receptor alpha deficiency impairs metabolic homeostasis and accelerates atherosclerotic lesion development. Proceedings of the National Academy of Sciences of the United States of America 2011, 108(39):16457-16462.
39. Couse J.F., Korach K.S. Estrogen receptor null mice: what have we learned and where will they lead us?. Endocrine Reviews 1999, 20(3):358-417.
40. Cowley S.M., et al. Estrogen receptors alpha and beta form heterodimers on DNA. Journal of Biological Chemistry 1997, 272(32):19858-19862.
41. Das S.K., et al. Estrogenic responses in estrogen receptor-alpha deficient mice reveal a distinct estrogen signaling pathway. Proceedings of the National Academy of Sciences of the United States of America 1997, 94(24):12786-12791.
42. Ohlsson C., et al. Obesity and disturbed lipoprotein profile in estrogen receptor-alpha-deficient male mice. Biochemical and Biophysical Research Communications 2000, 278(3):640-645.